Vai ai settori di specializzazione

Healthcare

Supporto strategico al tuo percorso di crescita

Con una tecnologia nuova e innovativa che sfida costantemente lo status quo, l’healthcare industry sta progredendo a passi da gigante. Ma in un settore basato su normative, i partenariati strategici sono spesso la chiave per sviluppare con successo le imprese.

I nostri advisors appassionati, supportati da team di sottosettori a livello globale, utilizzano la loro profonda esperienza per trovare il proprio vantaggio competitivo, navigare attraverso le dogane locali e aiutarti a creare la strategia più adatta.

Contatta l'advisor
Globali
472
deal chiusi in Healthcare
Globali
Esplora i nostri deal correlati ai settori di specializzazione
Vai ai deal
Cooper Consumer Health has sold Stardea to EA Pharma
Private Equity | Healthcare

Cooper Consumer Health has sold Stardea to EA Pharma

Cooper Consumer Health has sold Stardea to EA Pharma.

Per saperne di più
Enterprises ImportFab Inc. has been acquired by Labomar S.p.A
Healthcare | Private Equity

Enterprises ImportFab Inc. has been acquired by Labomar S.p.A

Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.

Per saperne di più
Xbrane Biosciences AB has aquired Primm Pharma
Healthcare

Xbrane Biosciences AB has aquired Primm Pharma

Xbrane Biosciences AB (Xbrane) has acquired Primm Pharma (Primm) for an undisclosed consideration.

Per saperne di più
“I am very happy with the deal we closed and I don’t think I could have expected a better outcome. The company I have built will continue to grow and my employees are protected. The Oaklins team did an amazing job. Their professionalism and dedication were beyond my expectations. I would highly recommend them to anyone looking for a financial advisor you can trust.”

Sylvain Renzi

Founder, Enterprises ImportFab, Inc.

Leggi di più
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=IT&includes=featured_images,tags&language=it&limit=1&tags=healthcare

Rimodellare le industrie: punti salienti delle fusioni e acquisizioni e visione strategica

QUARTERLY M&A ACTIVITY (EN): il secondo trimestre del 2024 ha segnato un periodo dinamico per Oaklins con 62 transazioni chiuse. Questa attività sottolinea l’adattabilità di vari settori alle condizioni di mercato in evoluzione e agli imperativi strategici.

Per saperne di più

Parla con i nostri local advisors

Antoine Collin

Managing Director
Milano, Italia
Oaklins Italy

Incontra i nostri specialisti della global industry

Antoine Lemaire

Partner
Parigi, Francia
Oaklins France

Robert Boersma

Partner
Amsterdam, Paesi Bassi
Oaklins Netherlands

Dino Theodorou

Director
Johannesburg, Sudafrica
Oaklins Grindrod

Stuart Goodman

Partner
Londra, Regno Unito
Oaklins Evelyn Partners

Michael Jewell

Partner
Londra, Regno Unito
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, Stati Uniti d’America
Oaklins TM Capital